LitAlert ~~ GeneLit.com

    • Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers.
    • Tan E, Whiting J, Knepper T, Xie H, Imanirad I, Carballido E, Felder S, Frakes J, Mo Q, Permuth JB, Somerer K, Kim R, Anaya DA, Fleming JB, Walko C, Sahin IH.
    • Am J Clin Oncol. 2022 Apr 1;45(4):137-141. doi: 10.1097/COC.0000000000000901.
    • Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients.
    • Gómez-Flores-Ramos L, Barraza-Arellano AL, Mohar A, Trujillo-Martínez M, Grimaldo L, Ortiz-Lopez R, Treviño V.
    • Cancers (Basel). 2022 Mar 24;14(7):1647. doi: 10.3390/cancers14071647.
    • Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer.
    • Wehbe A, Manning M, Assad H, Purrington KS, Simon MS.
    • Cancer Med. 2022 Mar 23. doi: 10.1002/cam4.4684. Epub ahead of print.
    • Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients.
    • Sivakumaran T, Krasovitsky M, Freimund A, Lee YC, Webber K, So J, Norris C, Friedlander M, Mileshkin L, Au-Yeung G.
    • Int J Gynecol Cancer. 2022 Mar 23:ijgc-2021-003009. doi: 10.1136/ijgc-2021-003009. Epub ahead of print.
    • Familial breast cancer, pregnancy and cardiotoxicity associated with the use of doxorubicin and reaction with trastuzumab.
    • Valente PMS, Gomes MCB, Martins WA, Castilho SR.
    • J Oncol Pharm Pract. 2022 Mar 23:10781552221080081. doi: 10.1177/10781552221080081. Epub ahead of print.
    • Case report